Skip to main content
FinSpry Logo
FinSpry
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$208.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AbbVie Inc. (ABBV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for AbbVie Inc. stock.

Analyst Consensus Rating

Investment consensus from 27 professional research analysts

Consensus Rating

Buy
Based on 27 unique analysts
(44 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$253.35
↑ 21.31% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ABBV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Luisa Hector
Berenberg Bank
BuyMaintains
$275.00
Mohit Bansal
Wells Fargo
BuyInitiates Coverage
$260.00
Louise Chen
Scotiabank
BuyMaintains
$280.00
Geoff Meacham
Citi
HoldMaintains
$230.00
Matt Phipps
William Blair
BuyMaintains
-
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyDowngrades
$239.00 → $261.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
HoldReiterates
$240.00 → $251.00
Chris Schott
JP Morgan
BuyMaintains
$260.00
Terence Flynn
Morgan Stanley
BuyMaintains
$269.00 → $270.00
Nico Chen
DBS
HoldMaintains
$230.00
Trung Huynh
RBC Capital
BuyInitiates
$260.00
Trung Huynh
RBC Capital
BuyInitiates
$260.00
Emily Field
Barclays
BuyInitiates
$275.00
Emily Field
Barclays
BuyInitiates
$275.00
David Amsellem
Piper Sandler
BuyMaintains
$289.00 → $299.00
Ilya Zubkov
Freedom Broker
Strong BuyMaintains
$245.00 → $260.00
Courtney Breen
Bernstein
HoldMaintains
$225.00
Louise Chen
Scotiabank
BuyMaintains
$280.00
Jason Gerberry
BofA Securities
HoldReiterates
$233.00 → $226.00
Michael Yee
UBS
HoldMaintains
$240.00 → $230.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$232.00 → $228.00
Terence Flynn
Morgan Stanley
BuyMaintains
$269.00 → $270.00
Google Drug Manufacturers - General
TipRanks - Google
BuyDowngrades
$227.00 → $250.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
HoldReiterates
$228.00 → $245.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$231.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
HoldReiterates
$229.00 → $231.00
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Matt Phipps
William Blair
BuyReiterates
-
Steve Scala
TD Cowen
BuyMaintains
$280.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$232.00 → $228.00
David Amsellem
Piper Sandler
BuyReiterates
$289.00
Asad Haider
Goldman Sachs
HoldMaintains
$223.00
Geoff Meacham
Citi
HoldMaintains
$235.00 → $230.00
Terence Flynn
Morgan Stanley
BuyMaintains
$269.00
Geoff Meacham
Citi
HoldMaintains
$235.00 → $230.00
Mohit Bansal
Wells Fargo
BuyMaintains
$260.00
Courtney Breen
Bernstein
HoldMaintains
$203.00 → $225.00
Luisa Hector
Berenberg Bank
BuyMaintains
$270.00 → $275.00
Jason Gerberry
BofA Securities
HoldReiterates
$233.00
Evan Seigerman
BMO Capital
BuyMaintains
$258.00
David Risinger
Leerink Partners
BuyMaintains
-
Rajesh Kumar
HSBC
BuyMaintains
$265.00
Alexandria Hammond
Wolfe Research
HoldDowngrades
-
Michael Yee
UBS
HoldInitiates
$220.00 → $240.00

Frequently Asked Questions

What is the analyst consensus rating for ABBV?

The analyst consensus rating for ABBV is "Buy" based on 27 analyst recommendations.

What is the average price target for ABBV?

The average 12-month price target for ABBV is $253.35, representing an upside of 21.3% from the current price of $208.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.